name: polypeptide N-acetylgalactosaminyltransferase 2 O-glycosylated 1 (human)

description: A polypeptide N-acetylgalactosaminyltransferase 2 (human) that has been O-glycosylated at the residue equivalent to Thr-368 of the amino acid sequence represented by UniProtKB:Q10471-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q10471-1, Thr-368, MOD:00005~GNO:G43417UB.


name: polypeptide N-acetylgalactosaminyltransferase 2 isoform h2 (human)

description: A polypeptide N-acetylgalactosaminyltransferase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q10471-2.


name: synaptophysin-like protein 2 isoform h1 (human)

description: A synaptophysin-like protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VXT5-1.


name: Locally Advanced Unresectable Gastric Adenocarcinoma

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A gastric adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


Metastatic Unresectable Carcinoma

description: A carcinoma that has spread from its original site of growth to another anatomic site and is not amenable to surgical resection.


name: Metastatic Unresectable Basal Cell Carcinoma

description: A basal cell carcinoma that has spread from its original site of growth to another anatomic site and is not amenable to surgical resection.


name: Locally Advanced Unresectable Esophageal Adenocarcinoma

description: Esophageal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Digestive System Adenocarcinoma

description: Digestive system adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma

description: Gastroesophageal junction adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Pancreatic Adenocarcinoma

description: A pancreatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Metastatic Unresectable Gastric Adenocarcinoma

description: A gastric adenocarcinoma that has spread from its original site of growth to another anatomic site and is not amenable to surgical resection.


name: Locally Advanced Unresectable Triple-Negative Breast Carcinoma

description: Triple-negative breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Colon Adenocarcinoma

description: A colon adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Basal Cell Carcinoma

description: A basal cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


Locally Advanced Unresectable Carcinoma

description: A carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Prostate Adenocarcinoma

description: A prostatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Breast Carcinoma

description: A breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Unresectable Castration-Resistant Prostate Carcinoma

description: Castration-resistant prostate carcinoma that is not amenable to surgical resection.


name: Locally Advanced Unresectable Renal Cell Carcinoma

description: A renal cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Colorectal Adenocarcinoma

description: A colorectal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma

description: A pancreatic ductal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable HER2-Negative Breast Carcinoma

description: A HER2-negative breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Cervical Adenocarcinoma

description: A cervical adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma

description: A non-small cell squamous carcinoma of the lung that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable HER2-Positive Breast Carcinoma

description: HER2-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Fallopian Tube Carcinoma

description: Fallopian tube carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma

description: Hormone receptor-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Prostate Carcinoma

description: A prostatic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Cervical Carcinoma

description: A cervical carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


Stage IA Uterine Sarcoma AJCC v7

description: Stage IA includes: T1a, N0, M0.  T1a: For leiomyosarcoma and endometrial stromal sarcoma: tumor 5 cm or less in greatest dimension.  For adenosarcoma: tumor limited to endometrium/endocervix.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)


name: transcription factor 7-like 2 sequence variant A397W (human)

description: A transcription factor 7-like 2 (human) that has a Trp residue at the position equivalent to Ala-397 of the amino acid sequence represented by UniProtKB:Q9NQB0-1. Example: UniProtKB:Q9NQB0-1, Ala-397, CHEBI:29954.


name: nephrosis-deafness-urinary tract-digital malformations syndrome

description: Nephrosis-deafness-urinary tract-digital malformations syndrome is characterized by anomalies of the urinary tract, thumbs and big toes, deafness and nephrosis. It has been described in five brothers. The mode of transmission has not been clearly established but seems to be either autosomal recessive or X-linked dominant.


name: zinc finger CCHC domain-containing protein 9 methylated 1 (human)

description: A zinc finger CCHC domain-containing protein 9 (human) that has been methylated on the residue at the position equivalent to Cys-186 of the amino acid sequence represented by UniProtKB:Q8N567. UniProtKB:Q8N567, Cys-186, MOD:00660.


benign neoplasm of tonsil

description: A benign neoplasm that involves the tonsil.


tonsillar lipoma

description: A benign adipose tissue neoplasm of the tonsils.


name: homeobox protein MIXL1 isoform h2 (human)

description: A homeobox protein MIXL1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H2W2-2.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit

description: A protein that is a translation product of the human NAA15 gene or a 1:1 ortholog thereof.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit methylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been methylated on the residue at the position equivalent to Cys-214 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Cys-214, MOD:00660.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit hydroxylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been hydroxylated on the residue at the position equivalent to Trp-258 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Trp-258, MOD:01622.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform h2 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BXJ9-4.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit cysteinylated 2 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been cysteinylated on the residue at the position equivalent to Cys-508 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Cys-508, MOD:00765.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform h1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BXJ9-1.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit phosphorylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been phosphorylated on the residue at the position equivalent to Tyr-66 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Tyr-66, MOD:00048.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit cysteinylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been cysteinylated on the residue at the position equivalent to Cys-214 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Cys-214, MOD:00765.


RuvB-like 1 methylated 1 (human)

A RuvB-like 1 (human) that has been methylated on the residue at the position equivalent to Cys-49 of the amino acid sequence represented by UniProtKB:Q9Y265-1. Example: UniProtKB:Q9Y265-1, Cys-49, MOD:00660.


name: ubiquitin conjugation factor E4 A methylated 1 (human)

description: A ubiquitin conjugation factor E4 A (human) that has been methylated on the residue at the position equivalent to Cys-490 of the amino acid sequence represented by UniProtKB:Q14139-1. Example: UniProtKB:Q14139-1, Cys-490, MOD:00660.


Volar Melanoma

description: A melanoma that arises from the palmar surface of hands and plantar surface of feet.


2-isothiocyanatoethyl phosphate

A monoalkyl phosphate that is ethyl phosphate in which one of the methyl hydrogens has been replaced by an isothiocyanato group.


name: anaphase-promoting complex subunit 2 isoform h1 (human)

description: An anaphase-promoting complex subunit 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UJX6-1.


name: F-box only protein 10 isoform h1 (human)

description: An F-box only protein 10 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UK96-1.


trivalent inorganic cation

An atom or small molecule with a positive charge that does not contain carbon in covalent linkage, with a valency of three.


Eccrine angiomatous hamartoma

description: A rare, congenital skin lesion consisting of a proliferation of eccrine glands with a vascular stroma. It presents as a flesh-colored, hyperhidrotic, painful papule or plaque appearing at birth or during childhood.


ubiquitin-conjugating enzyme E2 G2

A protein that is a translation product of the human UBE2G2 gene or a 1:1 ortholog thereof.


name: ubiquitin-conjugating enzyme E2 G2 isoform h2 (human)

description: A ubiquitin-conjugating enzyme E2 G2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P60604-2.


name: ubiquitin-conjugating enzyme E2 G2 isoform 1 (human)

description: A ubiquitin-conjugating enzyme E2 G2 isoform 1 that is encoded in the genome of human.


name: breast cancer type 2 susceptibility protein sequence variant K178* (human)

description: A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Pro-177 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-177.


name: coiled-coil domain-containing protein 7 isoform h2 (human)

description: A coiled-coil domain-containing protein 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96M83-2.


name: heterogeneous nuclear ribonucleoprotein U, initiator methionine removed form (human)

description: A heterogeneous nuclear ribonucleoprotein U (human) that has had the initiator methionine removed. UniProtKB:Q00839, 2-825.


name: membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 isoform h1 (human)

description: A membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86UL8-1.


protein EOLA1 isoform h2 (human)

A protein EOLA1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TE69-2.


protein EOLA1 isoform h1 (human)

A protein EOLA1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TE69-1.


name: alpha-1-antitrypsin N-glycosylated 1 (human)

description: An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G00912UN.


hereditary painful callosities

description: Hereditary painful callosities is a nummular palmoplantar keratoderma characterized by the development of painful keratotic lesions over pressure points in hands and feet. A few families have been described. Transmission is autosomal dominant. Successful analgesia can be obtained with tretinoin.


name: YTH domain-containing family protein 3 phosphorylated 1 (human)

description: A YTH domain-containing family protein 3 (human) that has been phosphorylated on the residue at the position equivalent to Thr-115 of the amino acid sequence represented by UniProtKB:Q7Z739. UniProtKB:Q7Z739, Thr-115, MOD:00047.


name: cytosolic carboxypeptidase 1 isoform h1 (human)

description: A cytosolic carboxypeptidase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UPW5-1.


name: glycerol-3-phosphate acyltransferase 4 isoform 1 (human)

description: A glycerol-3-phosphate acyltransferase 4 isoform 1 that is encoded in the genome of human.


homoallylic alcohol

An aliphatic alcohol where the hydroxy carbon is beta to a double bond.


A HDoHE obtained by hydroxylation at position 2 of all-cis-docosa-4,7,10,13,16,19-hexaenoic acid.


A hex-3-en-1-ol in which the double bond adopts a Z-configuration. Also known as leaf alcohol, it is emitted by green plants upon mechanical damage. Used as a flavourant in tea.


coprogen B

An Fe(III)-complexed hydroxamate siderophore with formula C33H51FeN6O12 that is secreted by several fungi and bacteria.


pyriculol

A benzaldehyde that is salicylaldehyde which is substituted at position 6 by a (3R,4S,5E)-3,4-dihydroxyhepta-1,5-dien-1-yl group. It is a phytotoxic metabolite, isolated from the rice blast fungi Magnaporthe oryzae and Magnaporthe grisea.


A HEPE obtained by hydroxylation at position 20 of all-cis-5,8,11,14,17-icosapentaenoic acid.


ferrirubin

A member of the class of ferrichromes that is an iron(III) chelate of the homodetic cyclic hexapeptide (cyclo{glycyl-L-seryl-L-seryl-N(5)-hydroxy-N(5)-[(2Z)-5-hydroxy-3-methyl-1-pent-2-enoyl]-L-ornithyl-N(5)-hydroxy-N(5)-[(2Z)-5-hydroxy-3-methyl-1-pent-2-enoyl]-L-ornithyl-N(5)-hydroxy-N(5)-[(2Z)-5-hydroxy-3-methyl-1-pent-2-enoyl]-L-ornithine


coprogen

An iron(III) hydroxamate isolated from fungi and bacteria including Penicillium species and Neurospora crassa. It is a growth factor for coprophilous fungi.


A primary alcohol that is hex-3-ene substituted by a hydroxy group at position 1.


desferricoprogen B

A member of the class of 2,5-diketopiperazines that is 2,5-diketopiperazine which is substituted at positions 3 and 6 by 3-(hydroxyamino)propyl groups in which the nitrogens have been acylated by (2E)-5-hydroxy-3-methylpent-2-enoyl groups. The substituent at position 3 has been further modified by having its terminal hydroxy group esterified by condensation with the carboxy group of N(5)-hydroxy-L-ornithine in which the N(5) nitrogen has been acylated by a (2E)-5-hydroxy-3-methylpent-2-enoyl group.


tuberonic acid

An oxo monocarboxylic acid that is (+)-7-isojasmonic acid in which one of the hydrogens of the side-chain methyl group is replaced by a hydroxy group.


An L-ornithine derivative obtained by formal condensation of the carboxy group of anhydromevalonic acid with the hydroxylamine nitrogen of N(5)-hydroxy-L-ornithine.


desferricoprogen

A member of the class of 2,5-diketopiperazines that is 2,5-diketopiperazine which is substituted at positions 3 and 6 by 3-(hydroxyamino)propyl groups in which the nitrogens have been acylated by (2E)-5-hydroxy-3-methylpent-2-enoyl groups. The substituent at position 3 has been further modified by having its terminal hydroxy group esterified by condensation with the carboxy group of N(2)-acetyl-N(5)-hydroxy-L-ornithine in which the N(5) nitrogen has been acylated by a (2E)-5-hydroxy-3-methylpent-2-enoyl group.


methyl tuberonate

A methyl ester derived from tuberonic acid.


A homoallylic alcohol that is 2-methylpent-2-ene in which a hydrogen of the methyl group at position 5 has been replaced by a hydroxy group.


12-hydroxyjasmonic acid

An oxo carboxylic acid that is jasmonic acid in which one of the hydrogens of the methyl group is replaced by a hydroxy group.


A benzaldehyde that is salicylaldehyde which is substituted at position 6 by a (3S,4S,5E)-3,4-dihydroxyhepta-1,5-dien-1-yl group. It is an epimer of pyriculol with stronger phytotoxic activity.


pyriculariol

A member of the class of benzaldehydes that is salicylaldehyde which is substituted at position 6 by a (1E,3E,5R,6S)-5,6-dihydroxyhepta-1,3-dien-1-yl group. An isomer of pyriculol.


dihydropyriculariol

A hydroxybenzyl alcohol that is pyriculariol in which the aldehyde goup has been reduced to the corresponding alcohol.


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (+)-12-hydroxy-7-isojasmonic acid with the amino group of L-isoleucine.


A hex-3-en-1-ol in which the double bond adopts an E-configuration.


(9Z)-12-hydroxyoctadec-9-enoic acid

A hydroxy fatty acid that is (9Z)-octadec-9-enoic (oleic) acid carrying a hydroxy substituent at position 12.


dihydropyriculol

A member of the class of benzyl alcohols resulting from the formal reduction of the aldehyde group of pyriculol. Produced by the rice blast fungus Magnaporthe oryzae.


isopentenyl alcohol

A primary alcohol having the structure of isopentyl alcohol but with a double bond between C-3 and one of the C-4 atoms.


6-tuliposide A

A 6-O-acyl-D-glucose that is the 6-O-(4-hydroxy-2-methylenebutanoyl) derivative of D-glucopyranose.


triricinolein

A triglyceride formed by acylation of the three hydroxy groups of glycerol with ricinoleic acid, ((9Z,12R)-12-hydroxydec-9-enoic acid). It is the main constituent of castor oil.


anhydromevalonyl-CoA

A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of anhydromevalonic acid.


A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 6-hydroxyhex-3-enoic acid.


marinolic acid C

An enoate ester resulting from the formal condensation of the carboxy group of (2E)-4-{(2S,3R,4R,5S)-3,4-dihydroxy-5-[(2E,4R,5S)-5-hydroxy-4-methylhex-2-en-1-yl]oxan-2-yl}-3-methylbut-2-enoic acid with the alcoholic hydroxy group of 8-hydroxyoctanoic acid.


diricinolein

A diglyceride in which any two of the R groups (positions not specified) are acyl groups specified as ricinoleoyl ((9Z,12R)-12-hydroxyoctadec-9-enoyl), while the remaining R group is H.


6-hydroxyhex-3-enoic acid

A medium-chain hydroxy fatty acid comprising 3-hexenoic acid carrying a 6-hydroxy substituent.


A glycol that is 1,4-butanediol substituted at position 2 by a methylidene group.


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (3R)-12-hydroxyjasmonic acid with the amino group of L-isoleucine.


name: Undifferentiated Juvenile Idiopathic Arthritis

description: A category of juvenile idiopathic arthritis that does not fulfill any single category or has criteria for more than one category.


name: zinc finger protein AEBP2 isoform h1 (human)

description: A zinc finger protein AEBP2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZN18-1.


name: vasopressin-neurophysin 2-copeptin sequence variant Q23R (human)

description: A vasopressin-neurophysin 2-copeptin (human) that has an Arg residue at the position equivalent to Gln-23 of the amino acid sequence represented by UniProtKB:P01185. UniProtKB:P01185, Gln-23, CHEBI:29952.


name: amyloid beta A4 precursor protein-binding family B member 1-interacting protein methylated 1 (human)

description: An amyloid beta A4 precursor protein-binding family B member 1-interacting protein (human) that has been methylated on the residue at the position equivalent to Cys-381 of the amino acid sequence represented by UniProtKB:Q7Z5R6-1. Example: UniProtKB:Q7Z5R6-1, Cys-381, MOD:00660.


name: pleckstrin homology domain-containing family A member 3 deaminated 1 (human)

description: A pleckstrin homology domain-containing family A member 3 (human) that has been deaminated on the residue at the position equivalent to Gln-288 of the amino acid sequence represented by UniProtKB:Q9HB20. UniProtKB:Q9HB20, Gln-288, MOD:00685.


name: pleckstrin homology domain-containing family A member 3

description: A protein that is a translation product of the human PLEKHA3 gene or a 1:1 ortholog thereof.


name: pleckstrin homology domain-containing family A member 3 cysteinylated 1 (human)

description: A pleckstrin homology domain-containing family A member 3 (human) that has been cysteinylated on the residue at the position equivalent to Cys-163 of the amino acid sequence represented by UniProtKB:Q9HB20. UniProtKB:Q9HB20, Cys-163, MOD:00765.


D-ribitol 5-phosphate

The 5-phospho derivative of D-ribitol.


name: calcium/calmodulin-dependent protein kinase type II subunit delta, initiator methionine removed form (human)

description: A calcium/calmodulin-dependent protein kinase type II subunit delta (human) that has had the initiator methionine removed. Example: UniProtKB:Q13557-1, 2-499.


name: inter-alpha-trypsin inhibitor heavy chain H2 O-glycosylated 23 (human)

description: An inter-alpha-trypsin inhibitor heavy chain H2 (human) that has been O-glycosylated at the residue equivalent to Thr-675 of the amino acid sequence represented by UniProtKB:P19823-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:P19823-1, Thr-675, MOD:00005~GNO:G57317CE.


name: elongation factor 1-gamma, initiator methionine removed form (human)

description: An elongation factor 1-gamma (human) that has had the initiator methionine removed. UniProtKB:P26641, 2-437.


magnetite nanoparticle

A nanoparticle consisting of magnetite, Fe(2+)Fe(3+)2O4.


name: Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage IVB includes: T0, N3, M0. T0: No evidence of primary tumor. N3: Metastasis in a cervical lymph node larger than 6 cm in greatest dimension and ENE(-); or metastases in a single ipsilateral cervical lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral cervical lymph nodes, any size and ENE(+) in any node. M0: No distant metastasis. (AJCC 8th Ed.)


name: Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage

description: A term that refers to the staging of unknown primary tumor (except for EBV-related and HPV-related tumors) and metastatic cervical adenopathy according to the American Joint Committee on Cancer, 8th edition.


name: Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage IVA includes: T0, N2, M0. T0: No evidence of primary tumor. N2: Metastasis in a single ipsilateral or contralateral cervical lymph node 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral cervical lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral cervical lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral cervical lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th Ed.)


name: Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage IVC includes: T0, Any N, M1. T0: No evidence of primary tumor. M1: Distant metastasis. (AJCC 8th Ed.)


name: Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8

description: Stage III includes: T0, N1, M0. T0: No evidence of primary tumor. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE (extranodal extension)(-). M0: No distant metastasis. (AJCC 8th Ed.)


name: Recurrent Metastatic Merkel Cell Carcinoma

description: The reemergence of a metastatic Merkel cell carcinoma after a period of remission.


Recurrent Metastatic Malignant Neoplasm

description: The reemergence of a metastatic malignant neoplasm after a period of remission.


Recurrent Metastatic Melanoma

description: The reemergence of metastatic melanoma after a period of remission.


Recurrent Carcinoma of Unknown Primary

description: The reemergence of carcinoma from an unknown primary after a period of remission.


name: Recurrent Metastatic Digestive System Carcinoma

description: The reemergence of a metastatic digestive system carcinoma after a period of remission.


Recurrent Pseudomyxoma Peritonei

description: The reemergence of pseudomyxoma peritonei after a period of remission.


name: Recurrent Metastatic Malignant Neoplasm in the Leptomeninges

description: The reemergence of a metastatic malignant neoplasm in the leptomeninges after a period of remission.


Recurrent Metastatic Gastric Carcinoma

description: The reemergence of metastatic gastric carcinoma after a period of remission.


name: Recurrent Metastatic Skin Squamous Cell Carcinoma

description: The reemergence of a metastatic skin squamous cell carcinoma after a period of remission.


CD40 ligand N-glycosylated 19 (human)

A CD40 ligand (human) that has been N-glycosylated at the residue equivalent to Asn-240 of the amino acid sequence represented by UniProtKB:P29965-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P29965-1, Asn-240, MOD:00160~GNO:G78059CC.


name: putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 cysteinylated 3 (human)

description: A putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (human) that has been cysteinylated on the residue at the position equivalent to Cys-265 of the amino acid sequence represented by UniProtKB:Q9NP73-1. Example: UniProtKB:Q9NP73-1, Cys-265, MOD:00765.


DIHYDROGEODIN

A member of the class of benzophenones that is sulochrin in which the hydrogens at positions 3 and 5 are substituted by chloro groups. It is isolated from several Aspergillus species.


protein EVI2A isoform h2 (human)

A protein EVI2A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22794-2.


name: nuclear receptor ROR-gamma isoform 1 (human)

description: A nuclear receptor ROR-gamma (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51449-1.


name: nuclear receptor ROR-gamma phosphorylated 1 (human)

description: A nuclear receptor ROR-gamma (human) that has been phosphorylated on the residue at the position equivalent to Ser-113 of the amino acid sequence represented by UniProtKB:P51449-1. Example: UniProtKB:P51449-1, Ser-113, MOD:00046.


name: nuclear receptor ROR-gamma isoform h2 (human)

description: A nuclear receptor ROR-gamma (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51449-2.


kazrin isoform h2 (human)

A kazrin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q674X7-2.


An optically active 1,2-diacylglycerol 3-diphosphate compound having a 1-hexadecanoyl substituent at the O-1 position and a (Z)-octadec-9-enoyl substituent at the O-2 position.


name: Deafness due to Connexin 26 Gene Anomaly

description: Congenital deafness caused by mutations in the gene GJB2 (deafness gene).


Complete neonatal hearing loss

description: Complete loss of the ability to detect or understand sounds present in an infant within its first month after birth.


Neonatal hearing loss

description: Partial or complete loss of the ability to detect or understand sounds present in an infant within its first month after birth.


name: autosomal recessive nonsyndromic hearing loss 1A

description: An autosomal recessive disorder caused by mutations in the GJB2 gene, encoding gap junction beta-2 protein. The condition is characterized by profound sensorineural hearing loss and may be associated with vestibular dysfunction.


central hearing loss

description: Hearing loss resulting from disorders of the central nervous system auditory pathways.


name: autosomal recessive nonsyndromic hearing loss 49

description: An autosomal recessive disorder caused by mutations in the MARVELD2 gene, encoding MARVEL domain-containing protein 2. The condition is characterized by profound prelingual deafness.


name: autosomal dominant nonsyndromic hearing loss 36

description: Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the TMC1 gene.


Hearing Loss, Functional

description: Hearing loss in the absence of auditory system pathology.


name: Mitochondrially Inherited Nonsyndromic Sensorineural Deafness

description: A maternally inherited form of nonsyndromic sensorineural deafness that is caused by a mutation in any of several mitochondrial genes.


Deafness, Autosomal Recessive 12

description: A genetic condition inherited in an autosomal recessive caused by mutation(s) in the CDH23 gene, encoding cadherin-23, characterized by progressive sensorineural hearing loss. Mutation(s) in the CDH23 gene may also cause Usher syndrome 1D.


name: autosomal recessive nonsyndromic hearing loss 36

description: Any autosomal recessive nonsyndromic deafness in which the cause of the disease is a mutation in the ESPN gene.


name: autosomal recessive nonsyndromic hearing loss 28

description: An autosomal recessive disorder caused by mutations in the TRIOBP gene, encoding TRIO and F-actin-binding protein. The condition is characterized by severe to profound sensorineural hearing loss.


Partial neonatal hearing loss

description: Partial loss of the ability to detect or understand sounds present in an infant within its first month after birth.


name: autosomal recessive nonsyndromic hearing loss 39

description: An autosomal recessive disorder caused by mutations in the HGF gene, encoding hepatocyte growth factor receptor. It is characterized by profound deafness.


name: autosomal dominant nonsyndromic hearing loss 41

description: Any autosomal dominant nonsyndromic deafness in which the cause of the disease is a mutation in the P2RX2 gene.


hearing loss, X-linked 4

description: Any X-linked nonsyndromic deafness in which the cause of the disease is a mutation in the SMPX gene.


Bilateral Deafness

description: Partial or total inability to hear sounds in both ears.


Deafness, Autosomal Dominant 58

description: A genetic condition inherited in an autosomal dominant fashion linked to chromosome 2p21-p12, characterized by bilateral hearing loss.


name: X-linked hereditary sensory and autonomic neuropathy with hearing loss

description: This syndrome is characterized by the association of an axonal sensory and autonomic neuropathy with hearing loss.


Sensory hearing loss

description: Hearing loss caused by damage to the cochlea in the inner ear.


name: severe intellectual disability-progressive spastic diplegia syndrome

description: Severe intellectual disability-progressive spastic diplegia syndrome is a rare condition that has been described in a few people with severe intellectual disability. Other signs and symptoms include progressive microcephaly (very small head); ataxia (lack of coordination); spasticity ; and/or skin, hair and mild facial anomalies. It is caused by changes (mutations) in the CTNNB1 gene and it is inherited in an autosomal dominant fashion. Treatment is based on the signs and symptoms present in each person.


name: immunoglobulin heavy constant mu N-glycosylated 16 (human)

description: An immunoglobulin heavy constant mu (human) that has been N-glycosylated at the residue equivalent to Asn-209 of the amino acid sequence represented by UniProtKB:P01871-2, in which the glycan structure is represented by GlyTouCan:G65219TP. Example: UniProtKB:P01871-2, Asn-209, MOD:00160~GNO:G65219TP.


T-cell antigen CD7 deaminated 1 (human)

A T-cell antigen CD7 (human) that has been deaminated on the residue at the position equivalent to Asn-121 of the amino acid sequence represented by UniProtKB:P09564. UniProtKB:P09564, Asn-121, MOD:00684.


hand dermatosis

description: Skin conditions characterized by dense infiltration of inflammatory cells (neutrophils) in the affected tissue. They arise in reaction to some underlying systemic illness. A neutrophilic dermatosis may be seen in isolation or more than one type may occur in the same individual.


ethyl (2E)-2-decenoate

A fatty acid ethyl ester obtained by the formal condensation of trans-2-decenoic acid with ethanol.


A glycophytoceramide having an alpha-D-galactopyranosyl residue at the O-1 position and a 6-(4-methoxyphenyl)hexanoyl group attached to the nitrogen.


arthus reaction

description: A localized vasculitis resulting from deposition of antibody-antigen complexes.


name: amyloid-beta precursor protein O-glycosylated 6 (human)

description: An amyloid-beta precursor protein (human) that has been O-glycosylated at the residue equivalent to Thr-367 of the amino acid sequence represented by UniProtKB:P05067-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05067-1, Thr-367, MOD:00005~GNO:G43417UB.


name: apoptotic chromatin condensation inducer in the nucleus phosphorylated 1 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that has been phosphorylated on the residue at the position equivalent to Ser-605 of the amino acid sequence represented by UniProtKB:Q9UKV3-1. Example: UniProtKB:Q9UKV3-1, Ser-605, MOD:00046.


name: apoptotic chromatin condensation inducer in the nucleus methylated 1 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that has been methylated on the residue at the position equivalent to Cys-1223 of the amino acid sequence represented by UniProtKB:Q9UKV3-1. Example: UniProtKB:Q9UKV3-1, Cys-1223, MOD:00660.


name: apoptotic chromatin condensation inducer in the nucleus isoform h4 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-5.


name: apoptotic chromatin condensation inducer in the nucleus isoform h1 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-1.


name: apoptotic chromatin condensation inducer in the nucleus isoform h2 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-2.


name: apoptotic chromatin condensation inducer in the nucleus isoform h3 (human)

description: An apoptotic chromatin condensation inducer in the nucleus (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKV3-3.


name: PALM2-AKAP2 fusion protein isoform 5 (human)

description: A PALM2-AKAP2 fusion protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y2D5-7.


name: collagen alpha-1(XV) chain O-glycosylated 16 (human)

description: A collagen alpha-1(XV) chain (human) that has been O-glycosylated at the residue equivalent to Thr-513 of the amino acid sequence represented by UniProtKB:P39059-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P39059-1, Thr-513, MOD:00005~GNO:G53434XO.


name: DNA-directed RNA polymerase II subunit RPB1 deaminated 5 (human)

description: A DNA-directed RNA polymerase II subunit RPB1 (human) that has been deaminated on the residue at the position equivalent to Gln-703 of the amino acid sequence represented by UniProtKB:P24928-1. Example: UniProtKB:P24928-1, Gln-703, MOD:00685.


name: 26S proteasome regulatory subunit 8 isoform h2 (human)

description: A 26S proteasome regulatory subunit 8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P62195-2.


name: 26S proteasome regulatory subunit 8 methylated 3 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been methylated on the residue at the position equivalent to Cys-363 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-363, MOD:00660.


name: 26S proteasome regulatory subunit 8 methylated 2 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been methylated on the residue at the position equivalent to Cys-112 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-112, MOD:00660.


name: 26S proteasome regulatory subunit 8 methylated 1 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been methylated on the residue at the position equivalent to Cys-209 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-209, MOD:00660.


name: 26S proteasome regulatory subunit 8 cysteinylated 1 (human)

description: A 26S proteasome regulatory subunit 8 (human) that has been cysteinylated on the residue at the position equivalent to Cys-209 of the amino acid sequence represented by UniProtKB:P62195-1. Example: UniProtKB:P62195-1, Cys-209, MOD:00765.


name: 26S proteasome regulatory subunit 8 isoform h1 (human)

description: A 26S proteasome regulatory subunit 8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P62195-1.


name: retinoblastoma-associated protein sequence variant S443*, initiator methionine removed form (human)

description: A retinoblastoma-associated protein (human) that has has been truncated after the position equivalent to Gly-442 of the amino acid sequence represented by UniProtKB:P06400 and that has had the initiator methionine removed. UniProtKB:P06400, 2-442.


name: serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform isoform 1 (human)

description: A serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform isoform 1 that is encoded in the genome of human.


name: Testicular Mixed Choriocarcinoma and Teratoma

description: A malignant mixed germ cell tumor arising from the testis.  It is characterized by the presence of a teratomatous component and malignant syncytiotrophoblastic cells.


eyelid degenerative disorder

description: A neurodegenerative disease that involves the eyelid.


name: EF-hand calcium-binding domain-containing protein 6 isoform h6 (human)

description: An EF-hand calcium-binding domain-containing protein 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5THR3-6.


name: B-cell antigen receptor complex-associated protein beta chain, signal peptide removed form (human)

description: A B-cell antigen receptor complex-associated protein beta chain (human) that has had the signal peptide removed. UniProtKB:P40259, 29-229.


name: B-cell antigen receptor complex-associated protein beta chain, signal peptide removed phosphorylated 1 (human)

description: A B-cell antigen receptor complex-associated protein beta chain (human) that has had the signal peptide removed and has been post-translationally modified to include phosphotyrosine at positions 196 and 207 of the amino acid sequence represented by UniProtKB:P40259. UniProtKB:P40259, 29-229, Tyr-196/Tyr-207, MOD:00048.


name: hyperphosphatasia with intellectual disability syndrome 2

description: Any hyperphosphatasia-intellectual disability syndrome in which the cause of the disease is a mutation in the PIGO gene.


name: potassium voltage-gated channel subfamily D member 3 isoform 2 (human)

description: A voltage-gated potassium channel KCND3 isoform 2 that is encoded in the genome of human.


External Prosthetic Device Pain

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Pain that is associated with an external artificial replacement device.


name: CCR4-NOT transcription complex subunit 2 isoform h2 (human)

description: A CCR4-NOT transcription complex subunit 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NZN8-2.


name: coatomer subunit epsilon methylated 1 (human)

description: A coatomer subunit epsilon (human) that has been methylated on the residue at the position equivalent to Cys-212 of the amino acid sequence represented by UniProtKB:O14579-1. Example: UniProtKB:O14579-1, Cys-212, MOD:00660.


name: alpha-N-acetylgalactosaminidase N-glycosylated 57 (human)

description: An alpha-N-acetylgalactosaminidase (human) that has been N-glycosylated at the residue equivalent to Asn-201 of the amino acid sequence represented by UniProtKB:P17050-1, in which the glycan structure is represented by GlyTouCan:G77252PU. Example: UniProtKB:P17050-1, Asn-201, MOD:00160~GNO:G77252PU.


name: p21-activated protein kinase-interacting protein 1 cysteinylated 1 (human)

description: A p21-activated protein kinase-interacting protein 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-87 of the amino acid sequence represented by UniProtKB:Q9NWT1. UniProtKB:Q9NWT1, Cys-87, MOD:00765.


A purine 2'-deoxyribonucleoside 5'-triphosphate having 8-oxo-7,8-dihydroguanine as the nucleobase.


Major microspecies at pH 7.3.


A purine 2'-deoxyribonucleoside 5'-triphosphate in which the 2'-deoxyribonucleoside moiety is 2'-deoxy-2-hydroxyadenosine.


dUTP

A deoxyuridine phosphate having a triphosphate group at the 5'-position.


ddTTP

A pyrimidine 2',3'-dideoxyribonucleoside 5'-triphosphate having thymine as the nucleobase.


A pyrimidine ribonucleoside 5'-triphosphate in which the pyrimidine element is 5-methyluracil.


A pyrimidine ribonucleoside 5'-triphosphate having 5-bromouracil as the pyrimidine component.


A 2'-deoxycytidine phosphate having 5-methylcytosine as the nucleobase.


A pyrimidine 2'-deoxyribonucleoside 5'-triphosphate that is 2'deoxycytidine-5'-triphosphate substituted by a hydroxymethyl group at position 5.


dITP

A deoxyinosine phosphate compound having a triphosphate group at the 5'-position.


DEOXYGUANOSINE TRIPHOSPHATE

A purine 2'-deoxyribonucleoside 5'-triphosphate having guanine as the nucleobase.


benign neoplasm of endometrium

description: A benign neoplasm that involves the endometrium.


name: disintegrin and metalloproteinase domain-containing protein 11 isoform Short (human)

description: A disintegrin and metalloproteinase domain-containing protein 11 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75078-2.


name: zinc finger and BTB domain-containing protein 14 isoform 1 (human)

description: A zinc finger and BTB domain-containing protein 14 isoform 1 that is encoded in the genome of human.


kit ligand isoform h3 (human)

A kit ligand (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P21583-3.


name: kit ligand isoform 1, signal peptide removed form (human)

description: A kit ligand isoform 1 (human) that has had the signal peptide removed. UniProtKB:P21583-1, 26-273.


kit ligand isoform 2 (human)

A kit ligand isoform 2 that is encoded in the genome of human.


kit ligand isoform 1 (human)

A kit ligand isoform 1 that is encoded in the genome of human.


neurotensin/neuromedin N

A protein that is a translation product of the human NTS gene or a 1:1 ortholog thereof.


name: Malignant nasopharyngeal neoplasm recurrent

description: The reemergence of a nasopharyngeal malignant neoplasm after a period of remission.


name: superoxide dismutase [Mn], mitochondrial, transit peptide removed form (human)

description: A superoxide dismutase [Mn], mitochondrial (human) that has had the transit peptide removed. UniProtKB:P04179, 25-222.


A nitrosamine that is dipropylamine in which the hydrogen attached to the nitrogen has been replaced by a nitroso group. It is a genotoxic carcinogen, targeting the lung, liver, thyroid, and kidney.


apolipoprotein L3 isoform h2 (human)

An apolipoprotein L3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95236-2.


name: general transcription factor IIH subunit 1 isoform h1 (human)

description: A general transcription factor IIH subunit 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P32780-1.


name: general transcription factor IIH subunit 1 deaminated 1 (human)

description: A general transcription factor IIH subunit 1 (human) that has been deaminated on the residue at the position equivalent to Asn-182 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Asn-182, MOD:00684.


name: general transcription factor IIH subunit 1 deaminated 2 (human)

description: A general transcription factor IIH subunit 1 (human) that has been deaminated on the residue at the position equivalent to Asn-375 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Asn-375, MOD:00684.


name: general transcription factor IIH subunit 1 isoform h2 (human)

description: A general transcription factor IIH subunit 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P32780-2.


name: general transcription factor IIH subunit 1 methylated 1 (human)

description: A general transcription factor IIH subunit 1 (human) that has been methylated on the residue at the position equivalent to Cys-181 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Cys-181, MOD:00660.


name: general transcription factor IIH subunit 1 cysteinylated 1 (human)

description: A general transcription factor IIH subunit 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-181 of the amino acid sequence represented by UniProtKB:P32780-1. Example: UniProtKB:P32780-1, Cys-181, MOD:00765.


olfactomedin-like protein 3

A protein that is a translation product of the human OLFML3 gene or a 1:1 ortholog thereof.


name: olfactomedin-like protein 3 N-glycosylated 5 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-248 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G69364JQ. Example: UniProtKB:Q9NRN5-1, Asn-248, MOD:00160~GNO:G69364JQ.


name: olfactomedin-like protein 3 N-glycosylated 4 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-248 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G65807AE. Example: UniProtKB:Q9NRN5-1, Asn-248, MOD:00160~GNO:G65807AE.


name: olfactomedin-like protein 3 isoform h3 (human)

description: An olfactomedin-like protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NRN5-3.


name: olfactomedin-like protein 3 N-glycosylated 1 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-177 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G19379ID. Example: UniProtKB:Q9NRN5-1, Asn-177, MOD:00160~GNO:G19379ID.


name: olfactomedin-like protein 3 isoform 1 (human)

description: An olfactomedin-like protein 3 isoform 1 that is encoded in the genome of human.


name: olfactomedin-like protein 3 N-glycosylated 3 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-177 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G83633GK. Example: UniProtKB:Q9NRN5-1, Asn-177, MOD:00160~GNO:G83633GK.


name: olfactomedin-like protein 3 N-glycosylated 2 (human)

description: An olfactomedin-like protein 3 (human) that has been N-glycosylated at the residue equivalent to Asn-177 of the amino acid sequence represented by UniProtKB:Q9NRN5-1, in which the glycan composition is represented by GlyTouCan:G50073PQ. Example: UniProtKB:Q9NRN5-1, Asn-177, MOD:00160~GNO:G50073PQ.


name: olfactomedin-like protein 3 isoform h2 (human)

description: An olfactomedin-like protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NRN5-2.


Lymphoma of kidney

description: A lymphoma that arises from the kidney. There is no evidence of a systemic lymphoproliferative disorder.


leukosialin O-glycosylated 167 (human)

A leukosialin (human) that has been O-glycosylated at the residue equivalent to Thr-58 of the amino acid sequence represented by UniProtKB:P16150-1, in which the glycan structure is represented by GlyTouCan:G60890ZT. Example: UniProtKB:P16150-1, Thr-58, MOD:00005~GNO:G60890ZT.


cholane derivative

Any steroid (or derivative) based on a cholane skeleton.


ursocholic acid

A bile acid that is 5beta-cholan-24-oic acid bearing three hydroxy substituents at positions 3alpha, 7beta and 12alpha.


allodeoxycholic acid

An allo-bile acid that is 5alpha-cholan-24-oic acid bearing two alpha-hydroxy substituents at position 3 and 12.


A steroid compound with a structure based on a 24-carbon (cholane) skeleton.


name: small ribosomal subunit protein eS8 cysteinylated 1 (human)

description: A small ribosomal subunit protein eS8 (human) that has been cysteinylated on the residue at the position equivalent to Cys-174 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Cys-174, MOD:00765.


name: small ribosomal subunit protein eS8 methylated 1 (human)

description: A small ribosomal subunit protein eS8 (human) that has been methylated on the residue at the position equivalent to Cys-100 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Cys-100, MOD:00660.


name: small ribosomal subunit protein eS8 methylated 2 (human)

description: A small ribosomal subunit protein eS8 (human) that has been methylated on the residue at the position equivalent to Cys-174 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Cys-174, MOD:00660.


name: 40S ribosomal protein S8, initiator methionine removed form (human)

description: A small ribosomal subunit protein eS8 (human) that has had the initiator methionine removed. UniProtKB:P62241, 2-208.


name: small ribosomal subunit protein eS8 isoform 1 (human)

description: A small ribosomal subunit protein eS8 isoform 1 that is encoded in the genome of human.


name: small ribosomal subunit protein eS8 deaminated 1 (human)

description: A small ribosomal subunit protein eS8 (human) that has been deaminated on the residue at the position equivalent to Asn-84 of the amino acid sequence represented by UniProtKB:P62241. UniProtKB:P62241, Asn-84, MOD:00684.


dystonin deaminated 5 (human)

A dystonin (human) that has been deaminated on the residue at the position equivalent to Asn-1210 of the amino acid sequence represented by UniProtKB:Q03001-7. Example: UniProtKB:Q03001-7, Asn-1210, MOD:00684.


name: versican core protein O-glycosylated 140 (human)

description: A versican core protein (human) that has been O-glycosylated at the residue equivalent to Thr-1996 of the amino acid sequence represented by UniProtKB:P13611-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P13611-1, Thr-1996, MOD:00005~GNO:G53434XO.


name: interleukin-1 alpha isoform 1 myristoylated 2 (human)

description: An interleukin-1 alpha isoform 1 myristoylated 2 in human. UniProtKB:P01583-1, Lys-82, MOD:00087.


name: interleukin-1 alpha isoform 1 myristoylated 1 (human)

description: An interleukin-1 alpha isoform 1 myristoylated 1 in human. UniProtKB:P01583-1, Lys-83, MOD:00087.


interleukin-1 alpha isoform 1 (human)

An interleukin-1 alpha isoform 1 that is encoded in the genome of human.


name: interleukin-1 alpha isoform 1 cleaved 1 (human)

description: An interleukin-1 alpha isoform 1 cleaved 1 in human. UniProtKB:P01583-1, 113-271.


name: C4b-binding protein alpha chain N-glycosylated 8 (human)

description: A C4b-binding protein alpha chain (human) that has been N-glycosylated at the residue equivalent to Asn-506 of the amino acid sequence represented by UniProtKB:P04003-1, in which the glycan composition is represented by GlyTouCan:G73686WG. Example: UniProtKB:P04003-1, Asn-506, MOD:00160~GNO:G73686WG.


name: follicular dendritic cell sarcoma of mediastinum

description: A rare follicular dendritic cell sarcoma that affects the structures of the mediastinum.


sorting nexin-33 isoform 1 (human)

A sorting nexin-33 isoform 1 that is encoded in the genome of human.


sorting nexin-33 deaminated 1 (human)

A sorting nexin-33 (human) that has been deaminated on the residue at the position equivalent to Gln-563 of the amino acid sequence represented by UniProtKB:Q8WV41. UniProtKB:Q8WV41, Gln-563, MOD:00685.


sorting nexin-33 deaminated 2 (human)

A sorting nexin-33 (human) that has been deaminated on the residue at the position equivalent to Gln-489 of the amino acid sequence represented by UniProtKB:Q8WV41. UniProtKB:Q8WV41, Gln-489, MOD:00685.


name: cell division control protein 6 homolog phosphorylated form (human)

description: A cell division control protein 6 homolog (human) that includes at least one phosphorylated residue. UniProtKB:Q99741, MOD:00696.


name: cell division control protein 6 homolog methylated 1 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-376 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-376, MOD:00660.


name: cell division control protein 6 homolog phosphorylated 1 (human)

description: A cell division control protein 6 homolog (human) that has been phosphorylated at Thr-37. UniProtKB:Q99741, Thr-37, MOD:00047.


name: cell division control protein 6 homolog methylated 3 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-156 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-156, MOD:00660.


name: cell division control protein 6 homolog methylated 4 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-493 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-493, MOD:00660.


name: cell division control protein 6 homolog deaminated 2 (human)

description: A cell division control protein 6 homolog (human) that has been deaminated on the residue at the position equivalent to Asn-308 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Asn-308, MOD:00684.


name: cell division control protein 6 homolog methylated 2 (human)

description: A cell division control protein 6 homolog (human) that has been methylated on the residue at the position equivalent to Cys-506 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-506, MOD:00660.


name: cell division control protein 6 homolog deaminated 3 (human)

description: A cell division control protein 6 homolog (human) that has been deaminated on the residue at the position equivalent to Gln-356 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Gln-356, MOD:00685.


name: cell division control protein 6 homolog deaminated 1 (human)

description: A cell division control protein 6 homolog (human) that has been deaminated on the residue at the position equivalent to Asn-342 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Asn-342, MOD:00684.


name: cell division control protein 6 homolog cysteinylated 1 (human)

description: A cell division control protein 6 homolog (human) that has been cysteinylated on the residue at the position equivalent to Cys-156 of the amino acid sequence represented by UniProtKB:Q99741. UniProtKB:Q99741, Cys-156, MOD:00765.


TOM1-like protein 2 isoform h5 (human)

A TOM1-like protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZVM7-5.


name: Acute Myeloid Leukemia with SF3B1 Mutation

description: An acute myeloid leukemia associated with SF3B1 gene mutation.


streptococcus pneumoniae discitis

description: Discitis caused by infection with Streptococcus pneumoniae.


name: vitamin K-dependent gamma-carboxylase isoform 1 (human)

description: A vitamin K-dependent gamma-carboxylase isoform 1 that is encoded in the genome of human.


name: lysosome-associated membrane glycoprotein 1, signal peptide removed form (human)

description: A lysosome-associated membrane glycoprotein 1 (human) that has had the signal peptide removed. Example: UniProtKB:P11279-1, 29-417.


atrial septal defect 9

description: Any atrial heart septal defect in which the cause of the disease is a mutation in the GATA6 gene.


name: interferon regulatory factor 7 isoform C (human)

description: An interferon regulatory factor 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92985-3.


name: interferon regulatory factor 7 phosphorylated 1 (human)

description: An interferon regulatory factor 7 (human) that has been post-translationally modified to include phosphoserine at positions 477 and 479 of the amino acid sequence represented by UniProtKB:Q92985. UniProtKB:Q92985, Ser-477/Ser-479, MOD:00046.


name: interferon regulatory factor 7 isoform D (human)

description: An interferon regulatory factor 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92985-4.


name: interferon regulatory factor 7 cysteinylated 1 (human)

description: An interferon regulatory factor 7 (human) that has been cysteinylated on the residue at the position equivalent to Cys-191 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-191, MOD:00765.


name: interferon regulatory factor 7 isoform A (human)

description: An interferon regulatory factor 7 isoform 1 that is encoded in the genome of human.


name: interferon regulatory factor 7 unmodified form (human)

description: An interferon regulatory factor 7 unmodified form in human.


name: interferon regulatory factor 7 ubiquitinated form (human)

description: An interferon regulatory factor 7 (human) that includes at least one ubiquitinated lysine. UniProtKB:Q92985, MOD:01148.


name: interferon regulatory factor 7 methylated 2 (human)

description: An interferon regulatory factor 7 (human) that has been methylated on the residue at the position equivalent to Cys-191 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-191, MOD:00660.


name: interferon regulatory factor 7 cysteinylated 2 (human)

description: An interferon regulatory factor 7 (human) that has been cysteinylated on the residue at the position equivalent to Cys-39 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-39, MOD:00765.


name: interferon regulatory factor 7 methylated 1 (human)

description: An interferon regulatory factor 7 (human) that has been methylated on the residue at the position equivalent to Cys-97 of the amino acid sequence represented by UniProtKB:Q92985-1. Example: UniProtKB:Q92985-1, Cys-97, MOD:00660.


name: interferon regulatory factor 7 isoform B (human)

description: An interferon regulatory factor 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92985-2.


name: interferon regulatory factor 7 isoform 1 unphosphorylated 1 (human)

description: An interferon regulatory factor 7 isoform 1 unphosphorylated 1 in human. UniProtKB:Q92985-1, Ser-477/Ser-479, PR:000026291.


name: Cdc42-interacting protein 4 isoform h4 (human)

description: A Cdc42-interacting protein 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15642-4.


name: phosphatase and actin regulator 1 isoform 1 (human)

description: A phosphatase and actin regulator 1 isoform 1 that is encoded in the genome of human.


name: atypical chemokine receptor 4 isoform 1 (human)

description: An atypical chemokine receptor 4 isoform 1 that is encoded in the genome of human.


name: Pancreatic Mucinous-Cystic Neoplasm, High Grade

description: A non-invasive mucinous cystic neoplasm that arises from the pancreas and is characterized by the presence of severe dysplasia.  The neoplastic columnar mucin-producing epithelial cells form papillae with irregular branching and budding.  There is nuclear stratification, prominent nucleoli, and cellular pleomorphism.  Mitotic activity is present and the mitoses may be atypical.


name: mitochondrial-processing peptidase subunit alpha cysteinylated 4 (human)

description: A mitochondrial-processing peptidase subunit alpha (human) that has been cysteinylated on the residue at the position equivalent to Cys-266 of the amino acid sequence represented by UniProtKB:Q10713-1. Example: UniProtKB:Q10713-1, Cys-266, MOD:00765.


name: NF-kappa-B inhibitor beta isoform h2 (human)

description: An NF-kappa-B inhibitor beta (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15653-2.


name: NF-kappa-B inhibitor beta isoform h1 (human)

description: An NF-kappa-B inhibitor beta (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15653-1.


name: NF-kappa-B inhibitor beta phosphorylated 1 (human)

description: An NF-kappa-B inhibitor beta (human) that has been post-translationally modified to include phosphoserine at positions 19 and 23 of the amino acid sequence represented by UniProtKB:Q15653. UniProtKB:Q15653, Ser-19/Ser-23, MOD:00046.


name: NF-kappa-B inhibitor beta phosphorylated and ubiquitinated 1 (human)

description: An NF-kappa-B inhibitor beta (human) that has been phosphorylated on the residues at the positions equivalent to Ser-19 and Ser-23 of the amino acid sequence represented by UniProtKB:Q15653-1 and that includes at least 1 ubiquitinated lysine. Example: UniProtKB:Q15653-1, Ser-19/Ser-23, MOD:00046|MOD:01148.


name: NF-kappa-B inhibitor beta methylated 1 (human)

description: An NF-kappa-B inhibitor beta (human) that has been methylated on the residue at the position equivalent to Cys-121 of the amino acid sequence represented by UniProtKB:Q15653-1. Example: UniProtKB:Q15653-1, Cys-121, MOD:00660.


A protein that is a translation product of the human SEMA6C gene or a 1:1 ortholog thereof.


semaphorin-6C isoform h3 (human)

A semaphorin-6C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H3T2-3.


semaphorin-6C isoform h1 (human)

A semaphorin-6C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H3T2-1.


semaphorin-6C isoform h2 (human)

A semaphorin-6C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H3T2-2.


name: Ral GTPase-activating protein subunit alpha-1 isoform h1 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6GYQ0-1.


name: Ral GTPase-activating protein subunit alpha-1 isoform h5 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6GYQ0-5.


name: Ral GTPase-activating protein subunit alpha-1 deaminated 1 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that has been deaminated on the residue at the position equivalent to Gln-417 of the amino acid sequence represented by UniProtKB:Q6GYQ0-1. Example: UniProtKB:Q6GYQ0-1, Gln-417, MOD:00685.


name: Ral GTPase-activating protein subunit alpha-1 isoform h4 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6GYQ0-4.


name: Ral GTPase-activating protein subunit alpha-1 isoform h2 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6GYQ0-2.


name: Ral GTPase-activating protein subunit alpha-1 isoform h3 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6GYQ0-3.


name: Ral GTPase-activating protein subunit alpha-1 isoform h6 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6GYQ0-6.


name: Ral GTPase-activating protein subunit alpha-1 isoform h7 (human)

description: A Ral GTPase-activating protein subunit alpha-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6GYQ0-7.


name: Parenteral Nutrition - Associated Cholestasis

description: Cholestasis that results from prolonged total parenteral nutrition. It is caused by diminished bile flow from the liver into the duodenum. It may result in cirrhosis and liver failure. Preterm infants are most susceptible to liver damage.


Recurrent Intrahepatic Cholestasis

description: Reappearance of cholestasis caused by obstruction within the liver.


Genital rhabdomyoma

description: A rare benign skeletal muscle neoplasm arising from the female genital tract. It is characterized by the presence of small nucleated rhabdomyoblasts within a fibrous and myxoid stroma.


Benign Skeletal Muscle Neoplasm

description: A benign mesenchymal neoplasm arising from skeletal muscle tissue.


Extracardiac Rhabdomyoma

description: A benign mesenchymal neoplasm that shows mature skeletal muscle differentiation.


Central Nervous System Rhabdomyoma

description: A benign mesenchymal neoplasm arising from the central nervous system.  It consists of mature skeletal muscle tissue.


Vulvar Rhabdomyoma

description: A rare benign polypoid skeletal muscle neoplasm arising from the vulva. It is characterized by the presence of round striated muscle cells and strap-like skeletal muscle cells, and vascular space formations within a fibrous and myxoid stroma.


Fetal rhabdomyoma

description: A rare benign mesenchymal neoplasm arising from skeletal muscle. It is characterized by the presence of immature spindle and polygonal cells within a scant myxoid stroma. It usually develops in the head and neck region of young children.


Paratesticular Rhabdomyoma

description: A rhabdomyoma that arises from the paratesticular region.


Vaginal Rhabdomyoma

description: A rare benign polypoid skeletal muscle neoplasm arising from the vagina.  It is characterized by the presence of round striated muscle cells and strap-like skeletal muscle cells, and vascular space formations within a fibrous and myxoid stroma.


Head and Neck Rhabdomyoma

description: A benign neoplasm with skeletal muscle differentiation that arises from the head and neck. It usually affects the mouth, parapharyngeal space, larynx, salivary glands, and soft tissue of the neck.


Intermediate Rhabdomyoma

description: A morphologic variant of fetal rhabdomyoma characterized by the presence of spindle cell myoblasts and strap-like skeletal muscle cells.


Adult Extracardiac Rhabdomyoma

description: A benign mesenchymal neoplasm arising from skeletal muscle and occurring in adults.


Classic Rhabdomyoma

description: A morphologic variant of fetal rhabdomyoma characterized by the presence of a prominent myxoid stroma and primitive skeletal spindle cells.


Mediastinal Rhabdomyoma

description: A rare benign skeletal muscle neoplasm arising from the mediastinum.


name: protein canopy homolog 2 isoform h1 (human)

description: A protein canopy homolog 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y2B0-1.


name: mediator of RNA polymerase II transcription subunit 23 deaminated 3 (human)

description: A mediator of RNA polymerase II transcription subunit 23 (human) that has been deaminated on the residue at the position equivalent to Gln-587 of the amino acid sequence represented by UniProtKB:Q9ULK4-1. Example: UniProtKB:Q9ULK4-1, Gln-587, MOD:00685.


pipamperone dihydrochloride

A hydrochloride resulting from the reaction of pipamperone with 2 mol eq. of hydrogen chloride. It is used as an antipsychotic.


atrial septal defect 7

description: Atrial septal defect (ASD) with atrioventricular conduction defects is an extremely rare genetic congenital heart disease characterized by the presence of ASD, mostly of the ostium secundum type, associated with conduction anomalies like atrioventricular block, atrial fibrillation or right bundle branch block.


mesenteric lymphadenitis

description: Inflammation of the mesenteric lymph nodes.


name: amyloidosis, primary localized cutaneous, 1

description: Any primary cutaneous amyloidosis in which the cause of the disease is a mutation in the OSMR gene.


name: familial primary localized cutaneous amyloidosis


name: amyloidosis, primary localized cutaneous, 3


name: amyloidosis, primary localized cutaneous, 2


LESPEFLORIN B3

A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 7 and 4' and prenyl groups at positions 6, 8 and 3'. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.


trihydroxyflavanone

A hydroxyflavanone carrying three hydroxy substituents.


example 15 [WO2015079413]

A flavanone glycoside that is eriodictyol attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It is an Nrf2 activator and provides protection against cisplatin-induced toxicity.


myrciacitrin III

A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 5', methyl group at positions 6 and 8 and a beta-D-glucopyranosyloxy residue at position 2'. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against aldose reductase.


glepidotin B

A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 5 and 7 and a prenyl group at position 8 respectively.


GARBANZOL

A member of the class of dihydroflavonols that is (2S)-flavanone substituted by hydroxy groups at positions 3, 7 and 4'.


LESPEFLORIN B2

A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 7 and 4' and prenyl groups at positions 6 and 8. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.


PINOBAKSIN

A trihydroxyflavanone in which the three hydroxy substituents are located at positions 3, 5 and 7.


A trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 3, 5 and 7 and methyl groups at positions 6 and 8 (the 2S,3S-stereoisomer). It has been isolated from the buds of Cleistocalyx operculatus and has been shown to exhibit inhibitory effects on the viral neuraminidases from two influenza viral strains, H1N1 and H9N2.


myrciacitrin V

A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 2' and 5', methyl groups at positions 6 and 8 and a (6''-O-p-hydroxybenzoyl)-beta-D-glucopyranosyloxy residue at position 7. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against aldose reductase.


myrciacitrin I

A flavanone glycoside that is (2S)-flavanone substituted by methyl groups at positions 6 and 8, hydroxy groups at positions 5, 2' and 5' and a beta-D-glucopyranosyloxy residue at position 7. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against alpha-glucosidase and aldose reductase.


fustin 3-O-beta-D-galactoside

A flavanone glycoside that consists of fustin attached to a beta-D-galactosyl moiety at position 3 via a glycosidic linkage.


(R)-naringenin

The (R)-enantiomer of naringenin.


PHELLAMURIN

A member of the class of dihydroflavonols that is (+)-dihydrokaempferol substituted by a prenyl group at position 8 and a beta-D-glucopyranosyl group at position 7 via a glycosidic linkage. Isolated from   Phellodendron amurense and Commiphora africana, it exhibits inhibition of intestinal P-glycoprotein.


A monosaccharide derivative that is  eriodictyol attached to a (6''-O-galloyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage.


myrciacitrin IV

A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 2' and 5', methyl groups at positions 6 and 8 and a (6''-O-p-coumaroyl)-beta-D-glucopyranosyloxy residue at position 7. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against aldose reductase.


A fucosyl oligoglycosylceramide consisting of ganglioside GM1 having an alpha-L-fucosyl residue attached at the 2-position of the galactose at the non-reducing end.


name: clathrin heavy chain 2 deaminated 1 (human)

description: A clathrin heavy chain 2 (human) that has been deaminated on the residue at the position equivalent to Asn-678 of the amino acid sequence represented by UniProtKB:P53675-1. Example: UniProtKB:P53675-1, Asn-678, MOD:00684.


name: RNA-binding protein 15 isoform h2 (human)

description: An RNA-binding protein 15 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96T37-2.


An N-acyllysophosphatidylethanolamine in which both the N- and O-acyl group are specified as palmitoyl (hexadecanoyl).


syringylresinol diacetate

A lignin that is the diacetate ester of syringylresinol.


4-methylaeruginoic acid

A 1,3-thiazole that is 4,5-dihydro-1,3-thiazole-4-carboxylic acid substituted by a 2-hydroxyphenyl group at position 2 and a methyl group at position 4 (the 4S stereoisomer). It is isolated from the culture broth of Streptomyces sp.KCTC9303 and exhibits potent cytotoxic activites against number of tumour cell lines.


name: Down syndrome critical region protein 8 isoform h5 (human)

description: A Down syndrome critical region protein 8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96T75-5.


name: Stage IB Fallopian Tube Cancer AJCC v6 and v7

description: Stage IB includes: T1b, N0, M0.  T1b: Tumor limited to both tubes, without penetrating the serosal surface; no ascites.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)


name: lymphocyte transmembrane adapter 1 isoform h1 (human)

description: A lymphocyte transmembrane adapter 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IWV1-1.


name: kelch-like protein 24 methylated 2 (human)

description: A kelch-like protein 24 (human) that has been methylated on the residue at the position equivalent to Cys-71 of the amino acid sequence represented by UniProtKB:Q6TFL4-1. Example: UniProtKB:Q6TFL4-1, Cys-71, MOD:00660.


14alpha-methyl steroid

Any steroid carrying a 14alpha-methyl substituent.


cullin-7 deaminated 1 (human)

A cullin-7 (human) that has been deaminated on the residue at the position equivalent to Gln-1302 of the amino acid sequence represented by UniProtKB:Q14999-1. Example: UniProtKB:Q14999-1, Gln-1302, MOD:00685.


name: Rho GTPase-activating protein 32 deaminated 1 (human)

description: A Rho GTPase-activating protein 32 (human) that has been deaminated on the residue at the position equivalent to Gln-1781 of the amino acid sequence represented by UniProtKB:A7KAX9-1. Example: UniProtKB:A7KAX9-1, Gln-1781, MOD:00685.


Expanding aneurysm

description: Expansion of aneurysm.


maresin 2

A dihydroxydocosahexaenoic acid that is (4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 13R- and 14S-positions.


A glycodohydroceramide having a 3-deoxy-alpha-D-galactopyranosyl residue at the O-1 position and an hexacosanoyl group attached to the nitrogen.


name: lutropin-choriogonadotropic hormone receptor isoform Long (human)

description: A lutropin-choriogonadotropic hormone receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P22888-1.


name: SLIT and NTRK-like protein 3, signal peptide removed form (human)

description: A SLIT and NTRK-like protein 3 (human) that has had the signal peptide removed. UniProtKB:O94933, 27-977.


name: follicular atrophoderma-basal cell carcinoma


name: kelch repeat and BTB domain-containing protein 6 hydroxylated 1 (human)

description: A kelch repeat and BTB domain-containing protein 6 (human) that has been hydroxylated on the residue at the position equivalent to Trp-415 of the amino acid sequence represented by UniProtKB:Q86V97. UniProtKB:Q86V97, Trp-415, MOD:01622.


name: kelch repeat and BTB domain-containing protein 6

description: A protein that is a translation product of the human KBTBD6 gene or a 1:1 ortholog thereof.


name: kelch repeat and BTB domain-containing protein 6 methylated 2 (human)

description: A kelch repeat and BTB domain-containing protein 6 (human) that has been methylated on the residue at the position equivalent to Cys-93 of the amino acid sequence represented by UniProtKB:Q86V97. UniProtKB:Q86V97, Cys-93, MOD:00660.


name: kelch repeat and BTB domain-containing protein 6 hydroxylated 2 (human)

description: A kelch repeat and BTB domain-containing protein 6 (human) that has been hydroxylated on the residue at the position equivalent to Trp-544 of the amino acid sequence represented by UniProtKB:Q86V97. UniProtKB:Q86V97, Trp-544, MOD:01622.


name: kelch repeat and BTB domain-containing protein 6 methylated 1 (human)

description: A kelch repeat and BTB domain-containing protein 6 (human) that has been methylated on the residue at the position equivalent to Cys-240 of the amino acid sequence represented by UniProtKB:Q86V97. UniProtKB:Q86V97, Cys-240, MOD:00660.


name: BMP receptor type-1B isoform 1 phosphorylated 1 (human)

description: A BMP receptor type-1B isoform 1 phosphorylated 1 in human.


name: proto-oncogene Wnt-3, signal peptide removed N-glycosylasparagine form (human)

description: A proto-oncogene Wnt-3 (human) that has had the signal peptide removed and that includes at least 1 N-glycosylated asparagine. UniProtKB:P56703, 22-355, MOD:00160.


name: mitochondrial adenyl nucleotide antiporter SLC25A23 isoform h3 (human)

description: A mitochondrial adenyl nucleotide antiporter SLC25A23 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BV35-3.


name: AT-rich interactive domain-containing protein 3B isoform h4 (human)

description: An AT-rich interactive domain-containing protein 3B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IVW6-4.


Metastatic Malignant Abdominal Neoplasm

description: A malignant neoplasm that arises from the abdomen and has spread from its original site of growth to another anatomic site.


Advanced Malignant Abdominal Neoplasm

description: A malignant neoplasm that arises from the abdomen and has spread extensively to other anatomic sites or is no longer responding to treatment.


Refractory Pleomorphic Liposarcoma

description: Pleomorphic liposarcoma that is resistant to treatment.


name: E3 ubiquitin-protein ligase pellino homolog 1 methylated 1 (human)

description: An E3 ubiquitin-protein ligase pellino homolog 1 (human) that has been methylated on the residue at the position equivalent to Cys-61 of the amino acid sequence represented by UniProtKB:Q96FA3. UniProtKB:Q96FA3, Cys-61, MOD:00660.


name: pleckstrin homology-like domain family A member 3

description: A protein that is a translation product of the human PHLDA3 gene or a 1:1 ortholog thereof.


name: sick sinus syndrome 2, autosomal dominant

description: Any sick sinus syndrome in which the cause of the disease is a mutation in the HCN4 gene.


protein SYS1 homolog isoform h2 (human)

A protein SYS1 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N2H4-2.


protein SYS1 homolog isoform 1 (human)

A protein SYS1 isoform 1 that is encoded in the genome of human.


20q11.2 microduplication syndrome

description: 20q11.2 microduplication syndrome is a rare chromosomal anomaly syndrome, due to partial duplication of the long arm of chromosome 20, characterized by psychomotor and developmental delay, moderate intellectual disability, metopic ridging/trigonocephaly, short hands and/or feet and distinctive facial features (epicanthus, hypoplastic supraorbital ridges, horizontal/downslanting palpebral fissures, small nose with depressed nasal bridge and anteverted nostrils, prominent cheeks, retrognathia and small, thick ears). Growth delay and cryptororchidism are often associated features.


name: GTP-binding protein Di-Ras2 isoform 1 (human)

description: A GTP-binding protein Di-Ras2 isoform 1 that is encoded in the genome of human.


ephrin-A3 isoform h2 (human)

An ephrin-A3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P52797-2.


ephrin-A3 isoform h1 (human)

An ephrin-A3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P52797-1.


ephrin-A3 deaminated 1 (human)

An ephrin-A3 (human) that has been deaminated on the residue at the position equivalent to Gln-85 of the amino acid sequence represented by UniProtKB:P52797-1. Example: UniProtKB:P52797-1, Gln-85, MOD:00685.


serpin E3 isoform h2 (human)

A serpin E3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MV23-2.


name: proliferating cell nuclear antigen sumoylated 1 (human)

description: A proliferating cell nuclear antigen (human) that has been sumoylated on the residues at the positions equivalent to Lys-164 and Lys-254 of the amino acid sequence represented by UniProtKB:P12004 and that includes at least 1 additional sumoylated lysine. UniProtKB:P12004, Lys-164/Lys-254, MOD:01149|MOD:01149.


name: eukaryotic translation initiation factor 5A-2 hypusinated 1 (human)

description: A eukaryotic translation initiation factor 5A-2 (human) that has been hypusinated on the residue at the position equivalent to Lys-50 of the amino acid sequence represented by UniProtKB:Q9GZV4. UniProtKB:Q9GZV4, Lys-50, MOD:00125.


name: potassium-transporting ATPase alpha chain 1, initiator methionine removed form (human)

description: A potassium-transporting ATPase alpha chain 1 (human) that has had the initiator methionine removed. UniProtKB:P20648, 2-1035.


name: potassium-transporting ATPase alpha chain 1 deaminated 1 (human)

description: A potassium-transporting ATPase alpha chain 1 (human) that has been deaminated on the residue at the position equivalent to Gln-775 of the amino acid sequence represented by UniProtKB:P20648. UniProtKB:P20648, Gln-775, MOD:00685.


cell surface hyaluronidase CEMIP2

A protein that is a translation product of the human CEMIP2 gene or a 1:1 ortholog thereof.


name: inactive cell surface hyaluronidase CEMIP2 isoform 1 (human)

description: A cell surface hyaluronidase CEMIP2 isoform 1 that is encoded in the genome of human.


name: inactive cell surface hyaluronidase CEMIP2 isoform h2 (human)

description: An inactive cell surface hyaluronidase CEMIP2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UHN6-2.


name: inactive cell surface hyaluronidase CEMIP2 cysteinylated 1 (human)

description: An inactive cell surface hyaluronidase CEMIP2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-1149 of the amino acid sequence represented by UniProtKB:Q9UHN6-1. Example: UniProtKB:Q9UHN6-1, Cys-1149, MOD:00765.


name: inactive cell surface hyaluronidase CEMIP2 phosphorylated 1 (human)

description: An inactive cell surface hyaluronidase CEMIP2 (human) that has been phosphorylated on the residue at the position equivalent to Thr-711 of the amino acid sequence represented by UniProtKB:Q9UHN6-1. Example: UniProtKB:Q9UHN6-1, Thr-711, MOD:00047.


A ribonucleoside 5'-monophosphate having methyl (2S)-2-amino-4-(6-methyl-9-oxo-4,9-dihydro-3H-imidazo[1,2-a]purin-7-yl)butanoate as the nucleobase.


name: sterol regulatory element-binding protein 2 methylated 1 (human)

description: A sterol regulatory element-binding protein 2 (human) that has been methylated on the residue at the position equivalent to Cys-762 of the amino acid sequence represented by UniProtKB:Q12772-1. Example: UniProtKB:Q12772-1, Cys-762, MOD:00660.


immunodeficiency 32B

description: A rare progressive disease that begins as a primary Epstein-Barr virus (EBV) infection. In this type of infection, the body makes too many lymphocytes (lymphoproliferative disease) for a period of more than 6 months duration. Lymphocytes are a type of white blood cell. They are an importantpart ofthe immune system because they help fight off diseases and protect the body from infection byproducing antibodies against viruses or bacteria and regulating immune responses. In CAEBV there are many antibodies againstEBV in the blood.Most people (about 95% of adults) get infected with EBV at some point in their lives, and never have any health problems.However, EBV can cause infectiousmononucleosis and other illnesses, and has a role in various autoimmune diseases and some types of cancer. While most infections occurring during childhood do not cause any symptoms,EBV infection in adolescents or young adults can often result in mononucleosis.After an EBV infection, the virus becomes latent (inactive) in the body, and, in some cases, the virus may reactivate. This does not always cause symptoms, but people with weakened immune systems are more likely to develop symptoms if EBV reactivates.In rare cases, people infected with EBV develop chronic active EBV virus infection(CAEBV) without apparent immunodeficiency. Most cases of CAEBV have been reported from Japan. These patientshave some of the complications found in otherwise-healthy patients with acute EBV infection, but unlike healthy patients, these complications persist and progress. Symptoms of CAEBV most often include fever, liverdysfunction, an enlarged spleen (splenomegaly), swollen lymph nodes (lymphadenopathy), and low numbers of platelets (thrombocytopenia) as well as high EBV-DNA load in the blood. Other features that appear in more than 10% of patients include enlarged liver (hepatomegaly), anemia, hypersensitivity to mosquito bites, rash, oral ulcers, hemophagocytic syndrome, coronary artery aneurysms, liver failure, lymphoma, and interstitial pneumonia. While the cause is yet unknown, researchers have identified defects in T cells or natural killer (NK) cells activity which results in a decreased defense against the EBV in people with CAEBV.It is important to note that the fatigue and malaise from acute infectious mononucleosis (IM)varies from mild symptoms lasting only a few weeks, to more severe symptoms of fatigue that can persist for several months, or even up to a year or more in up to 10% of patients (which may be considered a less severe form of chronicEBV infection). The persistence of fatigue that is seen in some patients after acute IM would lead some people to believe that EBV may also cause cases of chronic fatigue syndrome (CFS). However, no convincing link has been found between EBV and CFS.Hematopoietic stemcell transplantation has shown promise in the treatment of CAEBV.


name: melanocortin receptor 4 methylated 1 (human)

description: A melanocortin receptor 4 (human) that has been methylated on the residue at the position equivalent to Cys-293 of the amino acid sequence represented by UniProtKB:P32245. UniProtKB:P32245, Cys-293, MOD:00660.


name: serine/threonine-protein phosphatase 5, initiator methionine removed form (human)

description: A serine/threonine-protein phosphatase 5 (human) that has had the initiator methionine removed. UniProtKB:P53041, 2-499.


organosulfonic ester

An ester resulting from the formal condensation of the hydroxy group of an alcohol, phenol, heteroarenol, or enol with an organosulfonic acid.


methanesulfonate ester

An organosulfonic ester resulting from the formal condensation of methanesulfonic acid with the hydroxy group of an alcohol, phenol, heteroarenol, or enol.


ETHOFUMESATE

A racemate comprising of equimolar amounts of (S)- and (R)-ethofumesate.


A butan-4-olide having a 1-[(methylsulfonyl)oxy]ethyl group at the 3-position and two methyl substituents at the 5-position.


A butan-4-olide having a (4-nitrophenylsulfonyloxy)methyl group at the 3-position and two methyl substituents at the 5-position.


A butan-4-olide having a [1-(4-chlorophenylsulfonyl)oxy]ethyl group at the 3-position and two methyl substituents at the 5-position.


arenesulfonate ester

An organosulfonic ester resulting from the formal condensation of an arenesulfonic acid with the hydroxy group of an alcohol, enol, phenol or heteroarenol.